Policy for Funding Flash Glucose Monitoring for People with Diabetes
freestyle libre libre 2 diabetes type 1 diabetes type 1 type 2 diabetes type 2
Clinical Policies Drugs and Devices
BSW Ustekinumab Dose Escalation Policy for Crohn’s Disease
crohns Inflammatory bowel disease
BSW Infliximab Dose Escalation Policy for IBD
crohn’s disease crohns ulcerative colitis inflammatory bowel disease
BSW Vedolizumab Dose Escalation Policy for IBD
crohn’s disease crohns ulcerative colitis Inflammatory bowel disease
BSW Use of Qutenza Patches in Adults for Peripheral Neuropathic pain in non-diabetic patients: Prior Approval Form
Capsaicin qutenza neuropathic pain pain
BSW Qutenza patch (capsaicin 8%) for peripheral neuropathic pain in non-diabetic patients commissioning statement: Low priority intervention
Capsaicin qutenza neuropathic pain pain
Policy for dose escalation of Ustekinumab in psoriasis or psoriatic arthritis
Ustekinumab psoriasis psoriatic arthritis
Bevacizumab for the treatment of rubeotic/neovascular glaucoma and uncontrolled Proliferative Diabetic Retinopathy prior to laser or vitrectomy (adults)
Rubeotic glaucoma neovascular glaucoma Proliferative Diabetic Retinopathy bevacizumab
Policy for the use of sodium hyaluronic acid injections in osteoarthritis
Sodium hyaluronic acid osteoarthritis
Policy for use of Avastin® (bevacizumab) under the NICE threshold in wet AMD
Bevacizumab avastin wet AMD Ranibizumab Aflibercept